Avoro Capital Advisors LLC Increases Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]

Related Keywords

Recursos Ltda ,Nancyj Hutson ,Stevenk Galson ,Biocryst Pharmaceuticals ,Biocryst Pharmaceuticals Stock Performance ,Securities Exchange Commission ,Biocryst Pharmaceuticals Company Profile ,Needham Company ,Capstone Investment Advisors ,Tower Research Capital ,Quarter For Biocryst Pharmaceuticals ,Pinnacle Wealth Planning Services Inc ,Exchange Commission ,Nasdaq ,Avoro Capital Advisors ,News Ratings For Biocryst Pharmaceuticals Daily ,Biocryst Pharmaceuticals Inc ,Free Report ,Cryst Pharmaceuticals ,Capital Advisors ,Research Capital ,Gestao De Recursos ,Investment Advisors ,Pinnacle Wealth Planning Services ,Get Free Report ,Director Steven ,Director Nancy ,Visit Holdingschannel ,Biocryst Pharmaceuticals Daily ,